Open Philanthropy recommended an investment of $1,999,999 in Hemex Health to produce and distribute a rapid assay for the diagnosis of sickle cell disease, as well as diagnostic products for other diseases.
This falls within our work on scientific research, specifically within our interest in advancing human health and wellbeing.